PharmStockPharmacy Stock

Actonel
Actonel

5.58
A generic medicine indicated for bone health. Reduces bone mineral loss to support structural integrity and density.
Ingredient
Risedronate
Category
Bone Health
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Risedronate
Reference Brand
Risedronate
Product Origin
Generic Alternative
Reference Manufacturer
Procter & Gamble Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
Bisphosphonate
Pharmacological Class
Bone Resorption Inhibitor
Manufacturer Description
Developed to mitigate bone loss to support bone mineral density and alleviate fracture risk.
Mechanism of Action
Binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption, preventing structural degradation.
Route of Administration
Oral
Onset Time
1–3 months
Duration
12–24 hours
Contraindications
Hypocalcemia, Esophageal abnormalities, Inability to stand or sit upright for thirty minutes
Severe Adverse Events
Osteonecrosis of the jaw — requires immediate medical attention, Atypical femur fractures — requires immediate medical attention
Common Side Effects
Dyspepsia, Nausea, Abdominal pain
Uncommon Side Effects
Bone pain, Joint pain, Diarrhea
Drug Interactions
Calcium Supplements, Antacids
Pregnancy Safety Warnings
TGA Category C: Use only if benefits justify risks. Breastfeeding: Caution advised.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Fosamax, Didronel
Information related to Actonel is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Diabetes Management AU - Diabex Australia